Bisphosphonate (BP) group of drugs are used to treat patients with bone and calcium related disorders. Some of these patients are likely to seek orthodontic treatment. BP inhibits bone resorption and causes increased bone density which may adversely affect orthodontic tooth movement, impair bone healing and may even cause osteonecrosis of the jaw. This article presents a brief overview of the applied aspects of pharmacology, pharmacokinetics of the drug and the guidelines to plan and progress orthodontic treatment in patients on bisphosphonate therapy
Bisphosphonate, Orthodontic Treatment
